Bristol-Myers Squibb (BMY) News Today $57.01 +0.72 (+1.28%) As of 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period 5BMY : Bristol-Myers Squibb Options Trading: A Deep Dive into...January 21 at 7:10 PM | benzinga.comJim Cramer Says Bristol-Myers Squibb Company (BMY)’s ‘Got The One That Everybody Is Buzzing About’January 21 at 7:10 PM | msn.comBristol-Myers Squibb Company (NYSE:BMY) is largely controlled by institutional shareholders who own 77% of the companyJanuary 21 at 2:09 PM | uk.finance.yahoo.comBristol-Myers Squibb Company (BMY): A Bull Case TheoryJanuary 20 at 8:22 AM | insidermonkey.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by Corundum Group Inc.Corundum Group Inc. increased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 67.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,534 shares of the biopharmaceutical cJanuary 20 at 8:20 AM | marketbeat.comBigSur Wealth Management LLC Decreases Holdings in Bristol-Myers Squibb (NYSE:BMY)BigSur Wealth Management LLC cut its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 55.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,900 shares of the biopharmaceutical company's stock after seJanuary 20 at 7:44 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Acquired by UMB Bank n.a.UMB Bank n.a. lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 178.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 205,457 shares of the biopharmaceutical company's stockJanuary 20 at 7:33 AM | marketbeat.comM.E. Allison & CO. Inc. Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)M.E. Allison & CO. Inc. purchased a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 7,410 shares of the biopharmaceutical company's stockJanuary 20 at 7:07 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Stock Position Lessened by Gilman Hill Asset Management LLCGilman Hill Asset Management LLC decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 218,237 shares of the biopharmaceutical company's stock after selling 13,901 sharesJanuary 20 at 6:13 AM | marketbeat.comKrilogy Financial LLC Invests $570,000 in Bristol-Myers Squibb (NYSE:BMY)Krilogy Financial LLC acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,085 shares of the biopharmaceutical company's sJanuary 20 at 4:37 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Acquired by Merit Financial Group LLCMerit Financial Group LLC lifted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 34.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 42,435 shares of the biopharmaceutical company's stock after purchasing an additional 10,January 20 at 3:54 AM | marketbeat.comRomano Brothers AND Company Sells 6,801 Shares of Bristol-Myers Squibb (NYSE:BMY)Romano Brothers AND Company lowered its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 8.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 74,348 shares of the biopharmaceutical company's stock after selling 6,801 shares during the pJanuary 19 at 7:51 AM | marketbeat.comJackson Square Capital LLC Takes $1.37 Million Position in Bristol-Myers Squibb (NYSE:BMY)Jackson Square Capital LLC purchased a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 24,206 shares of the biopharmaceutical company's stock, valueJanuary 19 at 5:57 AM | marketbeat.comHB Wealth Management LLC Acquires 11,023 Shares of Bristol-Myers Squibb (NYSE:BMY)HB Wealth Management LLC boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 17.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 73,542 shares of the biopharmaceutical company's stock after purcJanuary 19 at 5:39 AM | marketbeat.comHennion & Walsh Asset Management Inc. Has $1.34 Million Position in Bristol-Myers Squibb (NYSE:BMY)Hennion & Walsh Asset Management Inc. cut its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 33.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 23,698 shares of the biopharmaceutical company's stock after selling 12,114 shJanuary 19 at 3:39 AM | marketbeat.comTrust Co. of Vermont Has $2.55 Million Position in Bristol-Myers Squibb (NYSE:BMY)Trust Co. of Vermont increased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 14.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,051 shares of the biopharmaceutical company'sJanuary 18 at 10:01 AM | marketbeat.comCohen Klingenstein LLC Sells 21,000 Shares of Bristol-Myers Squibb (NYSE:BMY)Cohen Klingenstein LLC decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 30.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,559 shares of the biopharmaceutical company's stock aJanuary 18 at 9:31 AM | marketbeat.comIntegrated Investment Consultants LLC Buys 14,292 Shares of Bristol-Myers Squibb (NYSE:BMY)Integrated Investment Consultants LLC raised its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 352,410 shares of the biopharmaceutical company's stock afJanuary 18 at 8:51 AM | marketbeat.comArkadios Wealth Advisors Buys 12,992 Shares of Bristol-Myers Squibb (NYSE:BMY)Arkadios Wealth Advisors boosted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 9.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 151,419 shares of the biopharmaceutical company'sJanuary 18 at 8:51 AM | marketbeat.comBrooklyn Investment Group Raises Stake in Bristol-Myers Squibb (NYSE:BMY)Brooklyn Investment Group boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 95.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 16,068 shares of the biopharmaceutical company's stock after purchasing an additional 7,866January 18 at 7:05 AM | marketbeat.comWedge Capital Management L L P NC Decreases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Wedge Capital Management L L P NC lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 19.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 515,398 shares of the biopharmaceutical company's stocJanuary 18 at 6:11 AM | marketbeat.comRitholtz Wealth Management Has $2.23 Million Position in Bristol-Myers Squibb (NYSE:BMY)Ritholtz Wealth Management increased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 65.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,389 shares of the biopharmaceutical comJanuary 18 at 4:41 AM | marketbeat.comAvanza Fonder AB Makes New $12.34 Million Investment in Bristol-Myers Squibb (NYSE:BMY)Avanza Fonder AB bought a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 218,226 shares of the biopharmaceutical company's stJanuary 17, 2025 | marketbeat.comWoodstock Corp Has $2.96 Million Stake in Bristol-Myers Squibb (NYSE:BMY)Woodstock Corp reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 12.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 52,267 shares of the biopharmaceutical company's stock afterJanuary 17, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Places Faith In Cobenfy for Alzheimer’s TreatmentJanuary 17, 2025 | tipranks.com8,382 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Decker Retirement Planning Inc.Decker Retirement Planning Inc. purchased a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 8,382 shares of the biopharmaceutical company's stock, valued at approximately $474,000. SJanuary 17, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Eagle Rock Investment Company LLCEagle Rock Investment Company LLC cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 52.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,824 shares of the biopharmaceutiJanuary 17, 2025 | marketbeat.comPark Avenue Securities LLC Purchases 13,952 Shares of Bristol-Myers Squibb (NYSE:BMY)Park Avenue Securities LLC grew its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 32.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,806 shares of the biopharmaceutical company's stock after purchaJanuary 17, 2025 | marketbeat.comLeerink Partnrs Has Positive Outlook for BMY Q4 EarningsJanuary 17, 2025 | americanbankingnews.comEarnings Preview: What To Expect From Bristol-Myers Squibb's ReportJanuary 16, 2025 | msn.com8,620 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Contravisory Investment Management Inc.Contravisory Investment Management Inc. purchased a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 8,620 shares of the biopharmaceutical company's stock, vaJanuary 16, 2025 | marketbeat.comFY2024 Earnings Forecast for BMY Issued By Leerink PartnrsJanuary 16, 2025 | americanbankingnews.comPositive Outlook for Bristol-Myers Squibb with Promising Market Access and Societal Benefits of CobenfyJanuary 15, 2025 | markets.businessinsider.comBristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drugJanuary 15, 2025 | cnbc.comMeyer Handelman Co. Sells 10,723 Shares of Bristol-Myers Squibb (NYSE:BMY)Meyer Handelman Co. lowered its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 553,168 shares of the biopharmaceutical company's stock after selliJanuary 15, 2025 | marketbeat.comRadnor Capital Management LLC Reduces Stake in Bristol-Myers Squibb (NYSE:BMY)Radnor Capital Management LLC decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 9.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 80,866 shares of the biopharmaceuticaJanuary 15, 2025 | marketbeat.comAcropolis Investment Management LLC Has $1.92 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Acropolis Investment Management LLC boosted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 39.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,009 shares of the biopharmaceutical company's stoJanuary 15, 2025 | marketbeat.comLeerink Partnrs Analysts Lift Earnings Estimates for BMYBristol-Myers Squibb (NYSE:BMY - Free Report) - Research analysts at Leerink Partnrs increased their Q4 2024 EPS estimates for Bristol-Myers Squibb in a report issued on Sunday, January 12th. Leerink Partnrs analyst D. Risinger now anticipates that the biopharmaceutical company will earn $1.42 peJanuary 15, 2025 | marketbeat.comBristol Myers CEO says new drug Cobenfy effective in schizophrenia, CNBC reportsJanuary 14, 2025 | markets.businessinsider.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by Wright Investors Service Inc.Wright Investors Service Inc. cut its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 25.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 89,613 shares of the biopharmaceutical company's stock after selling 30,168 shares during the period. BriJanuary 14, 2025 | marketbeat.comLeerink Partnrs Has Strong Forecast for BMY FY2024 EarningsBristol-Myers Squibb (NYSE:BMY - Free Report) - Analysts at Leerink Partnrs increased their FY2024 EPS estimates for shares of Bristol-Myers Squibb in a research note issued on Sunday, January 12th. Leerink Partnrs analyst D. Risinger now expects that the biopharmaceutical company will earn $0.90January 14, 2025 | marketbeat.comFNY Investment Advisers LLC Acquires 12,360 Shares of Bristol-Myers Squibb (NYSE:BMY)FNY Investment Advisers LLC grew its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 17,657.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,430 shares of the biopharmaceutical company's stock after purchasingJanuary 14, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Stake Raised by Brookstone Capital ManagementBrookstone Capital Management boosted its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 11.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 186,155 shares of the biopharmacJanuary 14, 2025 | marketbeat.comBristol Myers, ArsenalBio achieve milestone for AB-4000 seriesJanuary 13, 2025 | markets.businessinsider.comBristol sees annual $1.5B in cost savings by end of 2025January 13, 2025 | msn.comBristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)January 13, 2025 | seekingalpha.comBristol-Myers Squibb (BMY) Releases New Investor PresentationJanuary 13, 2025 | gurufocus.comMid American Wealth Advisory Group Inc. Sells 16,207 Shares of Bristol-Myers Squibb (NYSE:BMY)Mid American Wealth Advisory Group Inc. decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 18.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 69,662 shares of the biopharmaceutical company's stoJanuary 13, 2025 | marketbeat.comCapital Investment Advisors LLC Has $14.02 Million Stake in Bristol-Myers Squibb (NYSE:BMY)Capital Investment Advisors LLC trimmed its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 4.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 247,792 shares of the biopharmaceutical company'sJanuary 13, 2025 | marketbeat.comBristol-Myers Squibb Unveils Strategic Growth PlanJanuary 13, 2025 | tipranks.com Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼1.350.63▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼4428▲BMY Articles Average Week Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Corcept Therapeutics News Today Perrigo News Today Supernus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMY Stock Alerts